Publications
5674 Results
- Journal / Conference
- Society for Clinical Trials (May 16-19, 2021 Chicago, Il), oral, abst. CP-77
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
USAActions of a National Oncology Group to Manage the Impact of the COVID-19 Pandemic
- Journal / Conference
- Journal of Hematology & Oncology, Jun 23;14(1):96
- Year
- 2021
- Research Committee(s)
- Leukemia
- PMID
- PMID34162404
- PMC
- PMC8220739
A precision medicine classification for treatment of acute myeloid leukemia in older patients
- Journal / Conference
- JNCI Cancer Spectrum, Jul 28;5(5):pkab066. doi: 10.1093/jncics/pkab066. eCollection 2021 Oct.
- Year
- 2021
- Research Committee(s)
- Breast
- PMID
- PMID34485814
- PMC
- PMC8410139
Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo
- Journal / Conference
- American Society for Radiation Oncology (ASTRO) Annual Meeting (October 24-27, 2021), poster
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0809
The effect of radiation modality on outcomes of patients with resected extrahepatic cholangiocarcinoma or gallbladder carcinoma treated with adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine: a secondary analysis of SWOG S0809
- Journal / Conference
- American Journal of Human Genetics Oct 7;108(10):1852-1865. doi: 10.1016/j.ajhg.2021.09.002. Epub 2021 Sep 23.
- Year
- 2021
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID34559995
- PMC
- PMC8546220
- Study Number(s)
- S0000
A 584bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion, and confers risk of pancreatic cancer
- Journal / Conference
- Cancer Discovery Mar 1;12(3):644-653
- Year
- 2021
- Research Committee(s)
- Melanoma
- PMID
- PMID34764195 PMC8904282
- PMC
- PMC8904282
- Study Number(s)
- S1404
Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma
- Journal / Conference
- American Society of Hematology (Dec 11-14, 2021, Atlanta, GA), poster, #2425
- Year
- 2021
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1608
Trial-in-Progress: Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma (NCT#03269669): SWOG S1608
- Journal / Conference
- International Conference on Malignant Lymphoma 2021 (tentative June 2021), oral
- Year
- 2021
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0816
New prognostic score incorporating MTV predicts treatment failure in advanced Hodgkin Lymphoma
- Journal / Conference
- Society for Neuroncology (SNO) Annual Meeting (November 18-21, 2021, Boston), oral
- Year
- 2021
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9402
Cognitive Function And Quality Of Life In Long Term Survivors Of RTOG 9402
- Journal / Conference
- American Society of Human Genetics (ASHG) Annual Meeting (October 18-22), poster, PrgmNr 2776
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80405